No registrations found.
ID
Source
Brief title
Health condition
Post-ERCP pancreatitis
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome measure of this survey is exploration of the use and attitudes towards various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists.
Secondary outcome
1. Risk factor recognition for the development of post-ERCP pancreatitis
2. Guideline adherence to the 2019 ESGE Guidelines ‘ERCP related adverse events’
3. The presence and content of a post-ERCP pancreatitis prophylaxis protocol
4. Longitudinal comparison of answers from 2013 survey on the same subject by Dutch Pancreatitis Study Group (DPSG)
Background summary
Post-ERCP pancreatitis (PEP) is the most common complication of an endoscopic retrograde cholangiopancreaticography (ERCP), with serious risks of severe morbidity and mortality.
Various prophylactic measures for the prevention of PEP have been studied and implemented over the past years, namely rectal NSAID administration, prophylactic pancreatic duct (PD) stenting and intravenous hyperhydration. Practice differs between physicians worldwide, this has been demonstrated in earlier surveys on the subject. Numbers have not earlier been published on the practice of Dutch gastro-enterologists.
This survey is initiated by the Dutch Pancreatitis Study Group (DPSG) in order to establish the current clinical practice in the use of post-ERCP pancreatitis prophylaxis and recognition of risk factors for PEP amongst Dutch gastro-enterologists. The survey, which will be sent to Dutch gastroenterologists, consists of 47 questions on the various types of prophylaxis and possible risk factors. The primary outcome measure is exploration of the use of various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists. Secondary outcome measures are recognition of risk factors for PEP, guideline adherence, presence of PEP prophylaxis protocol and longitudinal comparison with 2013 survey.
This survey will give more clarity on current clinical practice in post-ERCP pancreatitis prophylaxis use and identify knowledge gaps between the clinical practice and guideline recommendations.
Study objective
We hypothesize that rectal NSAID prophylaxis use will have significantly risen in comparison to the 2013 survey.
We hypothesize biliary endoscopists will show a significantly better risk factor recognition than general gastroenterologists.
We hypothesize risk factors for post-ERCP pancreatitis will be recognized significantly more accurate than in the 2013 survey.
Study design
N/A
Intervention
Online survey
Inclusion criteria
BIG-registered physician specialized in gastroenterology
Exclusion criteria
1. Non- gastroenterology physicians
2. Residents
Design
Recruitment
IPD sharing statement
Plan description
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL8493 |
| Other | Radboud CMO : 2020-6375 |